研究生: |
陳家蓉 Chen, Chia Jung |
---|---|
論文名稱: |
(1)布忍斯特酸催化N-具取代腈胺與芳香胺反應:合成N,N’-二取代胍衍生物 (2)銅催化N-(2-溴苯基)-N’-芳香基胍的合環反應 (1)Synthesis of N,N’-disubstituted guanidine derivatives by Brønsted acid-catalyzed reaction of N-substituted cyanamides with arylamines (2)Copper-catalyzed cyclization reaction of N-(2-bromophenyl)-N’-arylguanidines |
指導教授: | 簡敦誠 |
學位類別: |
碩士 Master |
系所名稱: |
化學系 Department of Chemistry |
論文出版年: | 2016 |
畢業學年度: | 104 |
語文別: | 中文 |
論文頁數: | 26 |
中文關鍵詞: | N,N’-二取代胍 、2-苯基胺基苯并咪唑 、布忍斯特酸 |
英文關鍵詞: | acid-catalyzed, N,N'-diarylguanidines, pharmacological activities, 2-phenylaminobenzimidazoles |
DOI URL: | https://doi.org/10.6345/NTNU202205197 |
論文種類: | 學術論文 |
相關次數: | 點閱:149 下載:0 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
2-苯基胺基苯并咪唑 (2-phenylaminobenzimidazole) 與 N,N’-雙苯基胍基化合物(N,N’-diphenylguanidine) 是常見於擁有藥理活性重要化學骨架的含氮化合物。
含有 benzimidazole 的單元結構的化合物在生物活性上有良好的表現,包括對於抗腫瘤、抗高血壓、抗癲癇以及抗 HIV-1 病毒等方面;而含有苯并咪唑(benzimidazole) 單元結構的藥物,其藥理活性的研究也曾報導於先前的文獻。由於含有此結構的化合物有其重要性,有關它的合成方法一直以來是重要的研究議題。
由於 2-苯基胺基苯并咪唑 (2-phenylaminobenzimidazole) 分子結構可由 N,N’-雙苯基胍基化合物 (N,N’-diphenylguanidine) 進行分子內環化合成,因此我們將報導 (1)苯并咪唑 (benzimidazole) 的前驅物胍基化合物 (guanidine) 的合成研究,以及 (2) 探討苯并咪唑 (benzimidazole) 的合成。在本論文的第一部分的研究中,透過我們團隊先前所發表有效合成腈胺 (cyanamide) 的方法合成苯腈胺 (phenylcyanamide),進一步與含有推拉電子基團的苯胺 (aniline) 在布忍斯特酸 TsOH 的酸性環境下迴流生成N,N’-雙苯基胍基化合物 (N,N’-diphenylguanidine) 化合物,無論是以含推拉電子官能基團 (如 OMe,CH3 與 NO2 等) 的苯腈胺 (phenylcyanamide) 和苯胺 (aniline) 為起始物,在此合成途徑皆可以有不錯的反應性。
在第二部分,我們著重在探討苯并咪唑 (benzimidazole) 的合成。有趣地發現延伸第一部分研究成果,N,N’-雙苯胍基化合物 (N,N’-diphenylguanidine) 可以作為苯并咪唑 (benzimidazole) 的前驅物 2。我們團隊透過先前文獻探討 C-N 鍵生成的報導,以 Buchwald-Hartwig-type reaction、CuCl 為催化劑與 TMEDA 為 ligand 在鹼性條件下合成一系列 2-arylbenzimidazole 化合物。此合成途徑的反應條件相較於其他的合成途徑來得溫和,並且有引入多樣性的官能基,因此可以應用在相關藥物合成與材料合成等。
2-Phenylaminobenzimidazoles and N,N'-diarylguanidines are common nitrogencontaining chemical scaffolds which displayed a wide range of pharmacological activities, such as antitumor, anti-hypertension and anti-HIV-1 virus activities. Therefore, the synthesis of these nitrogen-containing compounds has always been of great interest to
organic chemists.
2-Phenylaminobenzimidazoles can be considered as a cyclic form of N,N'-diarylguanidines. Herein, we will discuss their background, importance and synthesis in two major parts. In the first part, our group has recently developed a novel approach for the synthesis of 2-phenylaminobenzimidazoles from benzonitriles and aniline derivatives.
A series of benzonitriles were treated with hydroxylamine to afford the amide oximes followed by the Tiemann rearrangement to afford the corresponding N-arylcyanamides. The acid-catalyzed guanidine formation from the reaction of N-arylcyanamides with anilines afforded a series of N,N’-diphenylguanidine-TsOH salts in good yields. The second part, we refer to the N,N’-diphenylguanidines possessed ortho-bromo substituent
were subjected to copper(I) chloride-catalyzed intramolecular C-N bond formation to give the desired 2-phenylaminobenzimidazoles. This is an operationally simple procedure that works at moderate condition with good yields and excellent N-regioselectivity.
Besides, base on various groups on N,N’-diphenylguanidine could bear this reaction codition, the synthesis could be used to related synthetic drugs and synthetic materials,
etc.
第二章 參考文獻
1. Berlinck, R. G. S.; Burtoloso, A. C. B.; Kossuga, M. H. Nat. Prod. Rep. 2008, 25, 919.
2. Berlinck, R. G. S.; Burtoloso, A. C. B.; Trindade-Silva, A. E.; Romminger, S.; Bandeira, R. P. K.; Mizuno, C. M. Nat. Prod. Rep. 2010, 27, 1871.
3. Berlinck, R. G. S.; Trindade-Silva, A. E.; Santos, M. F. C. Nat. Prod. Rep. 2012, 29, 1382.
4. Alan R. Katritzky; Boris V. Rogovoy. ARKIVOC. 2005, 4, 49.
5. Kovacevic, B.; Maksic, Z. B. Org. Lett. 2001, 3, 1523.
6. Martyn P. Coles. Chem. Commun., 2009, 3659.
7. Trifonov, A. A. Coord. Chem. Rev. 2010, 254, 1327.
8. Frank T. Edelmann. Chem. Soc. Rev. 2012, 41, 7657.
9. Terada, M. J. Synth. Org. Chem. Jpn. 2010, 68, 1159.
10. Lin, P.; Ganesan, A. Tetrahedron Lett. 1998, 39, 9789.
11. Gomez, L.; Gellibert, F.; Wagner, A.; Mioskowski, C. Chem. Eur. J. 2000, 6, 4016.
12. Ghosh, A. K.; Hol, W. G.; Fan, E. J. Org. Chem. 2001, 66, 2161.
13. Guisado, O.; Martinez, S.; Pastor, J. Tetrahedron Lett. 2002, 43, 7105.
14. Katritzky, A. R.; Khashab, N. M.; Bobrov, S. Helv. Chim. Acta, 2005, 88, 1664.
15. Yamamoto, Y.; Mizuno, H.; Tsuritani, T.; Mase, T. Tetrahedron Lett. 2009, 50, 5813.
16. Begue, D.; Qiao, G. G.; Wentrup, C. J. Am. Chem. Soc. 2012, 134, 5339.
17. Reddy, N. L.; Hu, L.-Y.; Cotter, R. E.; Fischer, J. B.; Wong, W. J.; McBurney, R. N.; Weber, E.; Holmes, D. L.; Wong, S. T. J. Med. Chem. 1994, 37, 260.
18. Hu, L.-Y.; Quo, J.; Magar, S. S.; Fischer, J. B.; Burke-Howie, K. J.; Durant, G. J. J. Med. Chem. 1997, 40, 4281.
19. Reddy, N. L.; Fan, W.; Magar, S. S.; Perlman, M. E.; Yost, E.; Zhang, L.; Berlove,D.; Fischer, J. B.; Burke-Howie, K.; Wolcott, T.; Durant, G. J. J. Med. Chem. 1998, 41, 3298.
20. Padmanabhan, S.; Perlman, M. E.; Zhang, L.; Moore, D.; Zhou, D.; Fischer, J. B.; Durant, G. J.; McBurney, R. N. Bioorg. Med. Chem. Lett. 2001, 11, 501.
21. Yong, Y. F.; Kowalski J. A.; Lipton, M. A. J. Org. Chem. 1997, 62, 1540.
22. Kent, D. R.; Cody, W. L.; Doherty, A. M. Tetrahedron Lett. 1996, 37, 8711.
23. Levallet, C.; Lerpiniere, J.; Ko, S. Y. Tetrahedron, 1997, 53, 5291.
24. O’Donovan, D. H.; Rozas, I. Tetrahedron Lett. 2011, 52, 4117.
25. Ramadas, K.; Srinivasan, N. Tetrahedron Lett., 1995, 36, 2841.
26. Dangate, P. S.; Akamanchi. K. G. Tetrahedron Lett. 2012, 53, 6765.
27. Feichtinger, K.; Zapf, C.; Sings, H. L.; Goodman, M. J. Org. Chem. 1998, 63, 3804.
28. Vaidyanathan,G.; Zalutsky, M. R. J. Org. Chem. 1997, 62, 4867.
29. Zhang, W. X.; Nishiura, M.; Hou, Z. M. Chem. Eur. J. 2007, 13, 4037.
30. Zhu, X.; Du, Z.; Xu, F.; Shen, Q. J. Org. Chem. 2009, 74, 6347.
31. Montilla, F.; del Rio, D.; Pastor, A.; Galindo, A. Organometallics, 2006, 25, 4996.
32. Zhu, X. H.; Xu, F.; Shen, Q. Chin. Sci. Bull. 2012, 57, 3419.
33. Mannepalli, L. K.; Dupati, V.; Vallabha, S. J.; Sunkara, V. M. J. Chem. Sci. 2013, 125, 1339.
34. Chen, J.; Wang, Y. B.; Luo, Y. J. Chin. J. Chem. 2013, 31, 1065.
35. Li; J.; Neuville, L. Org. Lett. 2013, 15, 6124.
36. Lin, C.-C.; Hsieh, T.-H.; Liao, P.-Y.; Liao, Z.-Y.; Chang, C.-W.; Shih, Y.-C.; Yeh, W.-H.; Chien, T.-C. Org. Lett. 2014, 16, 892.
37. Zeng, C.-J.; Chen,C.-J.; Chang,C.-W.; Chen, H.-T; Chien, T.-C. Aust. J. Chem. 2014, 67, 1134.
第四章 參考文獻
1. Shah, D. I.; Sharma, M.; Bansal, Y.; Bansal, G.; Singh, M. Eur. J. Med. Chem. 2008, 43, 1808.
2. Leoni, L. M. Semin. Hematol. 2011, 48, S4.
3. Shingalapur, R. V.; Hosamani, K. M.; Keri, R. S.; Hugar, M. H. Eur. J. Med. Chem. 2010, 45, 1753.
4. Zhan, P.; Chen, X. W.; Li, D. Y.; Fang, Z. J.; De Clercq, E.; Liu, X. Y. Med. Chem. Commun. 2013, 33, S1, E1.
5. Antivir Chem Chemother. 2002, 13, 345.
6. Janssens, F; Torremans, J.; Janssen, M.; Stokbroekx, Raymond A.; Luyckx, M.; Janssen, Paul A. J. J. Med. Chem. 1985, 28, 1934.
7. Seth, Punit P.; Jefferson, Elizabeth A.; Risen, Lisa M.; Osgood, Stephen A. Bioorg. Med. Chem. Lett. 2003, 13, 1669.
8. Ellingboe, John W.; Spine, Walter; Winkley, Michael W.; Nguyen, Thomas T.; Parsons, Roderick W.; Moubarak, Issam F.; Kitzen, Jan M.; Engen, Donna Von; Baglit, Jehan F. J. Med. Chem. 1992,35,705.
9. Patent No.: US 7960,561 B2
10. Kang, J.; Kim, H. S.; Jang, D. O. Tetrahedron Lett. 2005, 46, 6079.
11. Linschitz, H.; Grellmann, K. H. J. Am. Chem. Soc. 1964, 86, 303.
12. Verner, E.; Katz, B. A.; Spencer, J. R.; Allen, D.; Hataye, J.; Hruzewicz, W.; Hui, H. C.; Kolesnikov, A.; Li, Y.; Luong, C.; Martelli, A.; Radika, K.; Rai, R.; She, M.; Shrader, W.; Sprengeler, P. A.; Trapp, S.; Wang, J.; Young, W. B.; Mackman, R. L. J. Med. Chem. 2001, 44, 2753.
13. Vanden Eynde, J. J.; Delfosse, F.; Lor, P.; Van Haverbeke, Y. Tetrahedron, 1995, 51, 5813.
14. Chikashita, H.; Nishida, S.; Miyazaki, M.; Morita, Y.; Itoh, K. Bull. Chem. Soc. Jpn. 1987, 60, 737.
15. Pa¨tzold, F.; Zeuner, F.; Heyer, T. H.; Niclas, H.-J. Synth. Commun. 1992, 22, 281.
16. Bhatnagar, I.; George, M. V. Tetrahedron, 1968, 24, 1293.
17. Stephens, F. F.; Bower, J. D. J. Chem. Soc. 1949, 2971.
18. Beaulieu, P. L.; Hache, B.; Von Moos, E. Synthesis, 2003, 11, 1683.
19. Austen, S. C.; Kane, J. M. J. Heterocycl. Chem. 2001, 38, 979.
20. Lombardy, R. L.; Tanious, F. A.; Ramachandran, K.; Tidwell, R. R.; Wilson, W. D. J. Med. Chem. 1996, 39, 1452.
21. Das, B.; Holla, H.; Srinivas, Y. Tetrahedron Lett. 2007, 48, 61.
22. Ghorbani Vaghei, R.; Veisi, H. Mol. Diversity 2010, 14, 249.
23. Khosravi, K.; Kazemi, S. Chin. Chem. Lett. 2012, 23, 61.
24. Ben Alloum, A.; Bakkas, S.; Soufiaoui, M. Tetrahedron Lett. 1998, 39, 4481.
25. Lin, S. N.; Yang, L. H. Tetrahedron Lett. 2005, 46, 4315.
26. Cenini, S.; Ragaini, F.; Gallo, E.; Caselli, A. Curr. Org. Chem. 2011, 15, 1578.
27. Shen, M.; Driver, T. G. Org. Lett. 2008, 10, 3367.
28. Yong, K.; Manian, R. K.; Namjin, P.; Yumi, H.; Sunwoo, L. J. Org. Chem. 2011, 76, 9577.
29. Brasche, G.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47, 1932.
30. Qing X.; Wen-Hua W.; Gang L.; Fan-Ke M.; Jia-Hua C.; Zhen Y.; Zhang-Jie S. Chem. Eur. J. 2009, 15, 7292.
31. Alla, S. K.; Kumar, R. K.; Sadhu, P.; Punniyamurthy, T. Org. Lett. 2013, 15, 1334.
32. Devulapally, M.; Pradeep, S.; Tharmalingam, P. J. Org. Chem. 2015, 80, 1644.
33. Binh Nguyen, T.; Ermolenko, L.; Al-Mourabit, A. J. Am. Chem. Soc. 2013, 135, 118.
34. Brain, C. T.; Brunton, S. A. Tetrahedron Lett. 2002, 43, 1893.
35. Evindar, G.; Batey, R. A. Org. Lett. 2003, 5, 133.
36. Xin L.; Weiliang B. J. Org. Chem. 2009, 74, 5618.
37. Xiaohu D.; Heather M.; Neelakandha S. M. J. Org. Chem. 2009, 74, 5742.
38. Jinsong P.; Min Y.; Cuijuan Z.; Fangyun H.; Lingtong F.; Xiaoyan W.; Yufeng W.; Chunxia Chen. J. Org. Chem. 2011, 76, 716.